CD1A and acute lymphoblastic leukemia: Consistent with the pattern of expression of CD1a, we found that the novel UMG2 mAb strongly binds cortical-derived T-ALL cells, but not healthy peripheral blood cells, confirming a safe profile of expression of the epitope recognized.